GraniteShares Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-1,567
Closed -$348K 97
2023
Q2
$348K Sell
1,567
-52
-3% -$12.1K 0.31% 76
2023
Q1
$391K Sell
1,619
-19
-1% -$4.66K 0.35% 82
2022
Q4
$430K Sell
1,638
-286
-15% -$76.7K 0.36% 102
2022
Q3
$433K Sell
1,924
-200
-9% -$48.5K 0.35% 94
2022
Q2
$516K Sell
2,124
-428
-17% -$105K 0.38% 91
2022
Q1
$617K Sell
2,552
-201
-7% -$46.2K 0.33% 98
2021
Q4
$619K Buy
+2,753
New +$581K 0.29% 109

Other funds holding AMGN

GraniteShares Advisors's AMGN Position: Q3 2023 in Review

GraniteShares Advisors sold out of Amgen (AMGN) in Q3 2023, closing a stake of 1,567 shares — an estimated $348K sold.

GraniteShares Advisors first reported a position in AMGN in Q4 2021 and held it in 7 quarters. The position peaked at $619K in Q4 2021. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q3 2023.

  • GraniteShares Advisors reported no remaining Amgen position as of Q3 2023 after selling out during the quarter.
  • GraniteShares Advisors sold 1,567 Amgen shares in Q3 2023, an estimated $348K.
  • GraniteShares Advisors first reported a position in Amgen in Q4 2021 and held it in 7 quarters.
  • GraniteShares Advisors's Amgen position peaked at $619K in Q4 2021.
  • 2,501 funds tracked by Wall St. Rank held Amgen as of Q3 2023.

Based on GraniteShares Advisors's 13F filing for Q3 2023, filed 31 Oct 2023.